PMV Pharmaceuticals, Inc. (PMVP) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $37.98M | -7.1% |
| 2024 | $40.88M | +8.4% |
| 2023 | $37.71M | -65.2% |
| 2022 | $108.30M | -37.2% |
| 2021 | $172.47M | -52.3% |
| 2020 | $361.42M | +393.2% |
| 2019 | $73.28M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $37.98M | -7.1% |
| 2024 | $40.88M | +8.4% |
| 2023 | $37.71M | -65.2% |
| 2022 | $108.30M | -37.2% |
| 2021 | $172.47M | -52.3% |
| 2020 | $361.42M | +393.2% |
| 2019 | $73.28M | — |